CAS: 5812-07-7 - 3-(4-Dimethylaminobenzylidenyl)-2-indolinone
Formula:C17H16N2O
InChI:InChI=1S/C17H16N2O/c1-19(2)13-9-7-12(8-10-13)11-15-14-5-3-4-6-16(14)18-17(15)20/h3-11H,1-2H3,(H,18,20)
InChI key:InChIKey=UAKWLVYMKBWHMX-UHFFFAOYSA-N
SMILES:O=C1NC=2C=CC=CC2C1=CC3=CC=C(C=C3)N(C)C
- Synonyms:
- 2-Indolinone, 3-[p-(dimethylamino)benzylidene]-
- SU 4312
- 3-(4-Dimethylaminobenzylidenyl)-2-indolinone
- 3-[[4-(Dimethylamino)phenyl]methylene]-1,3-dihydro-2H-indol-2-one
- 2H-Indol-2-one, 3-[[4-(dimethylamino)phenyl]methylene]-1,3-dihydro-
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | 3-[4-(dimethylamino)benzylidene]indolin-2-one REF: IN-DA01CAMFCAS: 5812-07-7 | 98% | To inquire | Tue 07 Jan 25 |
 | SU 4312 REF: 7W-GK0280CAS: 5812-07-7 | - - - | To inquire | Tue 07 Jan 25 |
 | SU4312 REF: TM-T3570CAS: 5812-07-7 | 100% | 40.00 €~375.00 € | Tue 14 Jan 25 |
 | SU 4312 REF: 3D-FAA81207CAS: 5812-07-7 | Min. 95% | To inquire | Tue 18 Feb 25 |
![3-[4-(dimethylamino)benzylidene]indolin-2-one](https://static.cymitquimica.com/products/IN/thumb/DA01CAMF.jpg)
3-[4-(dimethylamino)benzylidene]indolin-2-one
CAS:5812-07-7
Formula:
C17H16N2O
Purity:
98%
Color and Shape:
Solid
Molecular weight:
264.3217
Ref: IN-DA01CAMF
| 10mg | 40.00 € | ||
| 25mg | 59.00 € | ||
| 100mg | 112.00 € |
Estimated delivery in United States, on Tuesday 7 Jan 2025
SU4312
CAS:5812-07-7
SU-4312 (DMBI) inhibits VEGFR & PDGFR (IC50: 0.8, 19.4 μM) and shields neurons from MPP(+)-induced …
Formula:
C17H16N2O
Purity:
100%
Color and Shape:
Solid
Molecular weight:
264.32
Ref: TM-T3570
| 1mg | 40.00 € | ||
| 2mg | 51.00 € | ||
| 5mg | 87.00 € | ||
| 10mg | 135.00 € | ||
| 25mg | 241.00 € | ||
| 50mg | 375.00 € |
Estimated delivery in United States, on Tuesday 14 Jan 2025
SU 4312
CAS:5812-07-7
SU 4312 is a synthetic molecule that binds to the alpha subunit of the human …
Formula:
C17H16N2O
Purity:
Min. 95%
Molecular weight:
264.33 g/mol
Ref: 3D-FAA81207
| 10mg | 304.00 € | ||
| 100mg | 1,140.00 € |
Estimated delivery in United States, on Tuesday 18 Feb 2025
